CSA C22.2 No. 60601-2-39-09 (2019): Safety Requirements for Peritoneal Dialysis Equipment

Understanding the Canadian Adoption of IEC 60601-2-39 for Peritoneal Dialysis Medical Devices

CSA C22.2 No. 60601-2-39-09 (2019) is the Canadian national adoption of IEC 60601-2-39, focusing on the particular safety requirements for peritoneal dialysis equipment. As part of the CSA C22.2 series of standards (Canadian Electrical Code, Part 2), this document ensures that medical electrical equipment used for peritoneal dialysis meets rigorous safety and performance criteria in both clinical and home settings. This article provides an overview of the standard’s scope, key technical requirements, implementation aspects, and compliance pathways.

Scope and Application

CSA C22.2 No. 60601-2-39-09 applies to peritoneal dialysis equipment, including automated cyclers, manual exchange devices, and associated accessories that are used for continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD). The standard covers equipment intended for use by healthcare professionals, patients, and caregivers. It modifies and supplements the general requirements of CSA C22.2 No. 60601-1 (IEC 60601-1) to address the unique hazards associated with peritoneal dialysis therapy.

Note: This standard does not apply to hemodialysis equipment, dialyzers, or blood tubing sets. It also excludes implantable components and devices used in dialysis solution preparation outside the device itself.

Key Technical Requirements

Electrical Safety and Performance

The standard mandates stringent limits for patient leakage currents, protective earth resistance, and dielectric strength. Peritoneal dialysis equipment must maintain patient leakage currents below 10 µA under normal conditions and 50 µA under single-fault conditions. Insulation requirements follow the two means of patient protection (MOPP) and two means of operator protection (MOOP) classification in line with IEC 60601-1 edition 3.

Fluid Path and Temperature Control

Equipment must control the temperature of infused dialysate within a defined range (typically 35–39 °C) to prevent patient discomfort or injury. Over-temperature protection must be fail-safe, with redundant thermostats or electronic limits. Fluid path materials must be biocompatible and resist chemical degradation from dialysate solutions. The standard also requires alarms for under/over temperature, flow obstruction, and air-in-line detection.

Alarm Systems

Alarm prioritization is defined in three levels: high priority (e.g., patient disconnect, pump failure), medium priority (e.g., minor occlusion), and low priority (system status). Audible and visual alarms must comply with IEC 60601-1-8, including specific alarm melodies for high priority events. Alarm cancellation shall not reset the underlying alarm condition.

Biocompatibility and Sterilization

Patient-contacting parts must comply with ISO 10993 series requirements for cytotoxicity, sensitization, and irritation. Sterilization processes (e.g., ethylene oxide, steam) must not leave harmful residues. The standard references CSA C22.2 No. 60601-1 for general biocompatibility considerations.

Tip: When designing dialysate heaters, ensure that the temperature control system includes both primary and secondary limits. Using two independent temperature sensors with separate logic can simplify compliance with the over-temperature protection requirement.
Key Performance and Safety Limits for Peritoneal Dialysis Equipment in CSA C22.2 No. 60601-2-39-09
Parameter Requirement / Limit Test Condition
Patient leakage current (normal) ≤ 10 µA Single fault condition (SFC)
Patient leakage current (SFC) ≤ 50 µA Single fault condition (SFC)
Maximum dialysate temperature 39 °C (setpoint) with over-temperature alarm at 41 °C Steady-state flow
Alarm response time (high priority) ≤ 10 seconds from fault detection As per risk analysis
Air-in-line detection threshold ≤ 0.02 mL for high priority alarm Verified with calibrated test setup
Protective earth resistance ≤ 0.1 Ω (power cord + internal) Measured at 10 A, 60 Hz
Biocompatibility (cytotoxicity) Grade 1 or less per ISO 10993-5 Extract method

Implementation and Testing Considerations

Risk Management

Manufacturers must conduct a thorough risk analysis per CSA C22.2 No. 60601-1 (IEC 60601-1) and ISO 14971. The risk assessment should address hazards including fluid contamination, over-infusion, air embolism, and electrical shock. Residual risks must be reduced to as low as reasonably practicable (ALARP). Safety margins for temperature, pressure, and flow should be justified with test data.

Usability Engineering

Given that peritoneal dialysis is often performed by patients at home, the standard requires user interface testing per IEC 60601-1-6 (usable design). Specific attention is given to alarms, label clarity, and error prevention during tube connection/disconnection. Formative and summative usability studies are expected.

Testing and Validation

Type testing must be performed on a single representative unit. Tests include:

  • Electrical leakage and dielectric strength at normal and fault conditions.
  • Temperature accuracy and over-temperature shutdown.
  • Accuracy of infused volume (e.g., ±2% of set volume).
  • Alarm function and latency.
  • Mechanical integrity of tubing and connectors.

All testing must be conducted under worst-case conditions as identified by the risk management process.

Warning: Subassemblies such as pumps and heaters must be subjected to accelerated endurance tests to verify long-term reliability. A failure in these components can directly compromise patient safety.

Compliance and Certification Notes

Certification Bodies

To market peritoneal dialysis equipment in Canada, compliance with CSA C22.2 No. 60601-2-39-09 must be demonstrated to an accredited certification body (CB) such as CSA Group, UL, or Intertek. The CB will audit the manufacturer’s quality system (typically ISO 13485) and conduct or witness type testing. Successful certification allows the manufacturer to apply the CSA mark.

Marking and Documentation

The device must be marked with:

  • Model, serial number, and date of manufacture.
  • Applied part classification (type BF or CF per IEC 60601-1).
  • Protection against ingress of liquids (e.g., IPX4).
  • Alarm classifications and meanings.

Technical documentation must include the risk management file, instructions for use (IFU), test reports, and a declaration of conformity. The IFU must be available in English and French.

Success Path: Many manufacturers choose to adopt IEC 60601-2-39:2009 as a primary reference and then produce a Canadian addendum highlighting any national differences. This approach streamlines global certification.

Frequently Asked Questions

Q: What is the main difference between CSA C22.2 No. 60601-2-39-09 and the international IEC 60601-2-39:2009?
A: The CSA version is technically identical to the 2009 edition of IEC 60601-2-39, but it includes Canadian national deviations pertaining to electrical ratings (e.g., 120 V / 60 Hz) and bilingual labeling requirements. It also references the Canadian Electrical Code (CSA C22.1) for installation aspects.
Q: Does this standard apply to dialysis solution bags and transfer sets?
A: No. The standard applies to the electromechanical equipment (e.g., cycler, heater). Consumables such as solution bags, tubing, and connectors are covered by other standards (e.g., ISO 8637 for hemodialyzers, ISO 8536 for infusion containers). However, the equipment manufacturer must ensure compatibility with the intended consumables.
Q: Are there specific requirements for software used in peritoneal dialysis equipment?
A: Yes. Software-controlled devices must comply with IEC 60601-1-4 (programmable electrical medical systems) and IEC 62304 (medical device software lifecycle processes). Risk management must cover software failures, including state transitions and alarm logic.
Q: What are the consequences of non-compliance with this standard in Canada?
A: Non-compliance can lead to denial of market access, product seizure, penalties, and liability in case of injury. Health Canada may also require a recall if safety issues are identified. Therefore, full compliance is mandatory through a recognized certification process.

© 2026 — All rights reserved.

📥 Standard Documents Download

🔒
Please wait 10 seconds, the download links will appear after the ad loads

Leave a Reply

Your email address will not be published. Required fields are marked *